Articles related to PANCREATIC CANCER

In a complex case of pseudomyxoma peritonei, detailed imaging and cytological analysis were crucial in identifying a rare pancreaticobiliary origin, highlighting the importance of a thorough diagnostic approach in unusual presentations of ascites.

Recent clinical case studies highlight that symptoms such as sudden changes in blood sugar levels and depressive episodes without clear psychological causes may be indicative of early-stage pancreatic cancer.

Abdominal cancer is no longer an ailment confined to older demographics, with a notable uptick in cases among younger adults. Physicians are urged to consider early screening, especially for patients with familial cancer histories, amidst growing concerns over lifestyle and environmental influences.

The FDA’s approval of irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin marks a pivotal advancement in first-line treatment options for metastatic pancreatic adenocarcinoma, showcasing a notable increase in overall and progression-free survival rates.

In a recent phase II trial, patients with untreated metastatic pancreatic ductal adenocarcinoma receiving sequential nab-P/Gem-mFOLFOX experienced a median overall survival of 13.2 months, compared to 9.7 months in those receiving standard nab-P/Gem treatment, indicating a notable improvement in survival outcomes.

Explore groundbreaking therapies in the pipeline: Onivyde for pancreatic cancer, showing marked survival benefits, and roluperidone, offering new hope in managing schizophrenia’s negative symptoms.